Literature DB >> 24767732

Recognizing and managing the immunologic reactions in leprosy.

Sonia Kamath1, Seth A Vaccaro1, Thomas H Rea1, Maria T Ochoa2.   

Abstract

Immunologic reactions are an important aspect of leprosy that significantly impacts the course of the disease and the associated disability. Reversal reaction (type 1), erythema nodosum leprosum (type 2), and Lucio phenomenon are the 3 leprosy reactions, and they are most commonly seen in patients with the lepromatous and borderline categories of the disease. Because these forms of leprosy are the most common types seen in the United States, it is particularly important for physicians to be able to recognize and treat them. The reactions may occur before, during, or after treatment with multidrug therapy. Reversal reactions are the most common cause of nerve damage in leprosy, and erythema nodosum leprosum may also lead to neuritis. Although there have not been enough studies to confirm the most effective management regimens, treatment of reversal reaction and Lucio phenomenon with prednisone and of erythema nodosum leprosum with thalidomide and/or prednisone may help improve symptoms and prevent further disability.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hansen disease; Lucio phenomenon; erythema nodosum leprosum; leprosy; reversal reaction; type 1 reaction; type 2 reaction

Mesh:

Substances:

Year:  2014        PMID: 24767732     DOI: 10.1016/j.jaad.2014.03.034

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  24 in total

1.  A Young Woman With Ulcerated Skin Lesions on Her Lower Extremities.

Authors:  Helen C Stankiewicz Karita; Carolina Stankiewicz Acosta; Jason D Simmons
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 2.  Neglected tropical rheumatic diseases.

Authors:  Rasmi Ranjan Sahoo; Anupam Wakhlu; Vikas Agarwal
Journal:  Clin Rheumatol       Date:  2022-02-10       Impact factor: 3.650

3.  Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic.

Authors:  Kristoffer E Leon; Jorge L Salinas; Robert W McDonald; Anandi N Sheth; Jessica K Fairley
Journal:  Am J Trop Med Hyg       Date:  2015-08-24       Impact factor: 2.345

4.  Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker.

Authors:  Fátima Regina Vilani-Moreno; Vânia Nieto Brito-de-Souza; Sônia Maria Usó Ruiz Silva; Adriana Sierra Assêncio Almeida Barbosa; Beatriz Gomes Carreira Sartori; Ana Paula Campanelli; Jaison Antonio Barreto; Marcos da Cunha Lopes Virmond
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

5.  Soil-transmitted helminth infections and leprosy: a cross-sectional study of the association between two major neglected tropical diseases in Indonesia.

Authors:  Salma Oktaria; Evita Halim Effendi; Wresti Indriatmi; Colette L M van Hees; Hok Bing Thio; Emmy Soedarmi Sjamsoe-Daili
Journal:  BMC Infect Dis       Date:  2016-06-08       Impact factor: 3.090

6.  Quality of life in patients with erythema nodosum leprosum in Kuala Lumpur, Malaysia.

Authors:  Felix B Yap; Sze T Kiung; Jeffrey B Yap
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

7.  Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.

Authors:  Veronica Schmitz; Rhana Berto da Silva Prata; Mayara Garcia de Mattos Barbosa; Mayara Abud Mendes; Sheila Santos Brandão; Thaís Porto Amadeu; Luciana Silva Rodrigues; Helen Ferreira; Fabrício da Mota Ramalho Costa; Jessica Brandão Dos Santos; Fabiana Dos Santos Pacheco; Alice de Miranda Machado; José Augusto da Costa Nery; Mariana de Andrea Hacker; Anna Maria Sales; Roberta Olmo Pinheiro; Euzenir Nunes Sarno
Journal:  PLoS Negl Trop Dis       Date:  2016-08-24

8.  Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO.

Authors:  Francianne M Amorim; Maurício L Nobre; Leonardo C Ferreira; Larissa S Nascimento; Alesson M Miranda; Glória R G Monteiro; Kathryn M Dupnik; Malcolm S Duthie; Steven G Reed; Selma M B Jeronimo
Journal:  PLoS Negl Trop Dis       Date:  2016-09-22

Review 9.  Innate Immune Responses in Leprosy.

Authors:  Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561

10.  Leprosy and American cutaneous leishmaniasis coinfection.

Authors:  Larissa Mondadori Mercadante; Marcel Alex Soares Dos Santos; Elisangela Samartin Pegas; Bogdana Victória Kadunc
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.